Engineered Immunomodulatory Accessory Cells Improve Experimental Allogeneic Islet Transplantation without Immunosuppression

Researchers engineered programmed death ligand-1 and cytotoxic T lymphocyte antigen 4 immunoglobulin fusion protein–modified mesenchymal stromal cells as accessory cells for islet cotransplantation.